HF
LIPO

HRT Financial’s Lipella Pharmaceuticals LIPO Stock Holding History

HRT Financial’s Portfolio LIPO Stock Details LIPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,202
Closed -$8K – 2883
2024
Q3 		$8K Buy
+2,202
New +$8.46K ﹤0.01% 2241
2024
Q2 		– Sell
-1,292
Closed -$7K – 2701
2024
Q1 		$7K Buy
+1,292
New +$9.62K ﹤0.01% 2093

Other funds holding LIPO

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's LIPO Position: Q4 2024 in Review

HRT Financial sold out of Lipella Pharmaceuticals (LIPO) in Q4 2024, closing a stake of 2,202 shares — an estimated $8K sold.

HRT Financial first reported a position in LIPO in Q1 2024 and held it in 2 quarters. The position peaked at $8K in Q3 2024. 3 funds tracked by Wall St. Rank hold LIPO as of Q4 2024.

  • HRT Financial reported no remaining Lipella Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • HRT Financial sold 2,202 Lipella Pharmaceuticals shares in Q4 2024, an estimated $8K.
  • HRT Financial first reported a position in Lipella Pharmaceuticals in Q1 2024 and held it in 2 quarters.
  • HRT Financial's Lipella Pharmaceuticals position peaked at $8K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Lipella Pharmaceuticals as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.